bcbs michigan glp 1 coverage cuts off weight-loss drugs for most Medicaid patients, saving $240M Coverage of Obesity Therapies in

In May 2025, a federal jury found that Amgen violated antitrust laws by bundling its cholesterol drug Repatha with unrelated anti-inflammatory drugs Enbrel and Otezla to secure preferential formulary placement with major PBMs

Medicare does not currently cover GLP-1s for weight loss alone only for diabetes, cardiovascular disease, or sleep apnea but a GLP-1 demonstration program for obesity is expected to begin in mid-2026 for some Medicare enrollees

Spread peanut butter across the flat side of your apple halves

By contrast, the Wegovy pill is a peptide-based large molecule drug that is more difficult for the body to absorb, requiring that a person take it on an empty stomach

(30) Additionally, the patient population differed from those in previous studies, as it excluded individuals with high cardiovascular risk